comparemela.com

Latest Breaking News On - Vascular group - Page 3 : comparemela.com

Positive Report for Medtronic (MDT) from Credit Suisse

Credit Suisse analyst Lorenzo Biasio upgraded Medtronic (MDT – Research Report) to a Buy yesterday and set a price target of $92.00. The c.

Morgan stanley ceciliaCoherus biosciencesLorenzo biasioEdwards lifesciencesCredit suisseRestorative therapies groupVascular groupInvasive technologies groupMedtronic plcDiabetes groupResearch reportMorgan stanleyCecilia furlongTruist financialMinimally invasive technologies group

10-Year Data from the Medtronic ENGAGE OUS Registry First and Only Prospective, Industry Sponsored Global EVAR Registry to Demonstrate a Decade of Durable Outcomes in Real-world Setting

Presented at Charing Cross, 10-Year Clinical Data from Global ENGAGE OUS Registry Support Endurant Stent Graft System’s AAA Market-Leading Position Worldwide

United kingdomCity ofCharing crossCarolyn sleethClinical event committeeErasmus university medical centerVascular groupInternational symposiumEndurant stent graft natural selection globalUcross symposiumHence verhagenEndurant stent graft systemClinical eventTen year outcomesEndurant stent graftEndovascular abdominal aortic aneurysm

Data shows durable outcomes with Medtronic stent graft system

Medtronic (NYSE:MDT) today announced positive results from its 10-year post-market registry for the Endurant stent graft.

City ofUnited kingdomCharing crossCarolyn sleethErasmus university medical centerVascular groupUcross symposiumHence verhagen

BTIG Sticks to Its Hold Rating for Medtronic (MDT)

BTIG analyst Ryan Zimmerman maintained a Hold rating on Medtronic (MDT – Research Report) today and set a price target of $350.00. The com.

Ryan zimmermanMorgan stanley ceciliaWells fargoRestorative therapies groupInvasive technologies groupMedtronic plcDiabetes groupVascular groupResearch reportMorgan stanleyCecilia furlongMinimally invasive technologies group

Bank of America Securities Sticks to Its Buy Rating for Medtronic (MDT)

In a report released today, Travis Steed from Bank of America Securities maintained a Buy rating on Medtronic (MDT – Research Report), wit.

United statesStifel nicolausAbbott labsVascular groupMedtronic plcInvasive technologies groupDiabetes groupRestorative therapies groupTravis steedAmerica securitiesResearch reportAxonics modulationModerate buyMinimally invasive technologies group

vimarsana © 2020. All Rights Reserved.